• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典艰难梭菌性小肠结肠炎的诊断与流行病学

Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden.

作者信息

Aronsson B, Möllby R, Nord C E

出版信息

J Antimicrob Chemother. 1984 Dec;14 Suppl D:85-95. doi: 10.1093/jac/14.suppl_d.85.

DOI:10.1093/jac/14.suppl_d.85
PMID:6520069
Abstract

Experience of the diagnosis and epidemiology of Clostridium difficile in Sweden is reviewed. Samples from 5885 patients have been investigated at the National Bacteriological Laboratory in Stockholm from 1978-1983. Patients originate from all parts of the country and their number continues to increase. Cl. difficile seem to be of growing importance, especially in nosocomial infections. Most patients with antibiotic-associated diarrhoea and colitis (AAD/AAC) and Cl. difficile in their stools were above 60 years of age (63%) and there was a significant preponderance of females over males in the age groups 21-50 and above 60 years of age. The antibiotics most commonly associated with Cl. difficile enterocolitis (CDE) were penicillins, cephalosporins and clindamycin/lincomycin. On the basis of consumption clindamycin/lincomycin and cephalosporins are associated 70 and 40 times, respectively, more often than penicillins in CDE. Diagnosis of CDE relies mainly on detection of the cytotoxin (toxin B) in stool specimens. It was present in 873/4793 (18.2%) patients whereas the bacterium was found in only 12%. An immunoassay for detection of the enterotoxin (toxin A) of Cl. difficile seems to be a useful alternative to the cytotoxin assay, but some stool specimens with a low toxin B titre were negative. Five specimens negative for toxin B were positive for toxin A and came from patients where additional information suggested CDE. A serological assay for demonstration of circulating antibodies to Cl. difficile toxins has also been evaluated and is positive in about half of the cases of CDE. Antibody response seems to be absent or delayed in patients with relapse of colitis after antibiotic treatment.

摘要

本文回顾了瑞典艰难梭菌的诊断和流行病学经验。1978年至1983年期间,斯德哥尔摩国家细菌学实验室对5885名患者的样本进行了调查。患者来自瑞典全国各地,且数量持续增加。艰难梭菌的重要性似乎日益凸显,尤其是在医院感染方面。大多数患有抗生素相关性腹泻和结肠炎(AAD/AAC)且粪便中存在艰难梭菌的患者年龄在60岁以上(63%),在21至50岁以及60岁以上年龄组中,女性明显多于男性。与艰难梭菌性小肠结肠炎(CDE)最常相关的抗生素是青霉素、头孢菌素和克林霉素/林可霉素。基于药物使用情况,在CDE中,克林霉素/林可霉素和头孢菌素与CDE的关联频率分别比青霉素高70倍和40倍。CDE的诊断主要依赖于粪便标本中细胞毒素(毒素B)的检测。在4793名患者中有873名(18.2%)检测到细胞毒素,而仅12%的患者检测到该细菌。一种用于检测艰难梭菌肠毒素(毒素A)的免疫测定法似乎是细胞毒素测定法的有用替代方法,但一些毒素B滴度较低的粪便标本检测结果为阴性。5份毒素B检测阴性的标本毒素A检测呈阳性,这些标本来自其他信息提示患有CDE的患者。一种用于检测针对艰难梭菌毒素的循环抗体的血清学测定法也已得到评估,在大约一半的CDE病例中呈阳性。抗生素治疗后结肠炎复发的患者似乎没有抗体反应或抗体反应延迟。

相似文献

1
Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden.瑞典艰难梭菌性小肠结肠炎的诊断与流行病学
J Antimicrob Chemother. 1984 Dec;14 Suppl D:85-95. doi: 10.1093/jac/14.suppl_d.85.
2
Pathogenesis and diagnosis of clostridium difficile enterocolitis.艰难梭菌性小肠结肠炎的发病机制与诊断
Scand J Infect Dis Suppl. 1985;46:47-56.
3
Clostridium difficile and antibiotic associated diarrhoea in Sweden.瑞典的艰难梭菌与抗生素相关性腹泻
Scand J Infect Dis Suppl. 1982;35:53-8.
4
Lack of value of repeat stool testing for Clostridium difficile toxin.艰难梭菌毒素重复粪便检测的价值缺失
Am J Med. 2006 Apr;119(4):356.e7-8. doi: 10.1016/j.amjmed.2005.08.026.
5
Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects.瑞典艰难梭菌相关性小肠结肠炎的诊断。实验室及流行病学方面
Scand J Infect Dis Suppl. 1980(Suppl 22):30-6.
6
[Epidemiology of Clostridium difficile infection].艰难梭菌感染的流行病学
Przegl Epidemiol. 2002;56(1):49-56.
7
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.急性肠道疾病中的抗菌药物与艰难梭菌:1980 - 1982年瑞典的流行病学数据
J Infect Dis. 1985 Mar;151(3):476-81. doi: 10.1093/infdis/151.3.476.
8
[Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].[艰难梭菌腹泻:在阿根廷布宜诺斯艾利斯一家医疗中心的检出频率]
Rev Argent Microbiol. 2001 Apr-Jun;33(2):101-7.
9
Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.耐氟喹诺酮、毒素A阴性、毒素B阳性艰难梭菌的出现与控制
Infect Control Hosp Epidemiol. 2007 Aug;28(8):932-40. doi: 10.1086/519181. Epub 2007 Jun 29.
10
Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.用于艰难梭菌感染诊断的首要毒素A和B检测法与TOX A/B II检测法的比较
Clin Vaccine Immunol. 2008 Mar;15(3):575-8. doi: 10.1128/CVI.00282-07. Epub 2008 Jan 2.

引用本文的文献

1
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.老年人艰难梭菌性腹泻:当前问题与管理选项
Drugs Aging. 2015 Aug;32(8):639-47. doi: 10.1007/s40266-015-0289-2.
2
N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.加拿大的耐艰难梭菌相关性腹泻(N-CDAD):1997年加拿大医院感染监测计划N-CDAD患病率监测项目的结果
Can J Infect Dis. 2001 Mar;12(2):81-8. doi: 10.1155/2001/304098.
3
Clostridium difficile: a pathogen of the nineties.
Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):137-41. doi: 10.1007/BF01691108.
4
Clostridium difficile: clinical disease and diagnosis.艰难梭菌:临床疾病与诊断
Clin Microbiol Rev. 1993 Jul;6(3):251-65. doi: 10.1128/CMR.6.3.251.
5
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.司帕沙星的多剂量药代动力学及其对粪便菌群的影响。
Antimicrob Agents Chemother. 1994 Mar;38(3):455-9. doi: 10.1128/AAC.38.3.455.
6
Monospecific antibodies for detection of Clostridium difficile enterotoxin.用于检测艰难梭菌肠毒素的单特异性抗体。
Eur J Clin Microbiol. 1987 Feb;6(1):62-4. doi: 10.1007/BF02097196.
7
Incidence and significance of Clostridium difficile in hospitalized cancer patients.住院癌症患者艰难梭菌的发病率及意义
Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):274-8. doi: 10.1007/BF01963101.
8
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.环丙沙星的药代动力学及重复给药对唾液和粪便微生物群的影响。
Antimicrob Agents Chemother. 1986 Feb;29(2):298-302. doi: 10.1128/AAC.29.2.298.
9
Treatment of Clostridium difficile-associated disease with teicoplanin.用替考拉宁治疗艰难梭菌相关性疾病。
Antimicrob Agents Chemother. 1989 Jul;33(7):1125-7. doi: 10.1128/AAC.33.7.1125.
10
Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery.单剂量抗生素预防术后艰难梭菌肠道定植和疾病的前瞻性研究。
Antimicrob Agents Chemother. 1991 Jan;35(1):208-10. doi: 10.1128/AAC.35.1.208.